Chief Financial Officer
CurrentBoard Member since May 2019 and CFO from April 2024. Enable is creating the next generation of ultra-sensitive and highly specific antibody detection predictive medicine based on co-Board member, Dr. Caroline Bertozzi's, 2022 Nobel Science Prize-winning "click-chemistry" research. Spun out of UC Berkeley and Stanford in 2016 it has partnered with Stanford Healthcare, Harvard Medical School, California Department of Public Health, Juvenile Diabetes Research Foundation, Mayo Clinic, Gates Foundation, and many others.